Literature DB >> 3056521

Insulin-metal ion interactions: the binding of divalent cations to insulin hexamers and tetramers and the assembly of insulin hexamers.

F D Coffman1, M F Dunn.   

Abstract

An insulin hexamer containing one B10-bound Co(III) ion and one unoccupied B10 site has been synthesized. The properties of the monosubstituted hexamer show that occupancy of only one B10 site by Co3+ is sufficient to stabilize the hexameric form under the conditions of pH and concentration used in these studies. The experimentally determined, second-order rate constants for the binding of Zn2+ and Co2+ to the unoccupied B10 site are consistent with literature rate constants for the rate of association of these divalent metal ions with similar small molecule ligands. These findings indicate that the rate-limiting steps for Zn2+ and Co2+ binding involve the removal of the first aqua ligand. The rate constant for the binding of Cd2+ is significantly lower than the literature values for small molecule chelators, which suggests that some other protein-related process is rate-limiting for Cd2+ binding to the unoccupied, preformed B10 site. The kinetics of the assembly of insulin in the presence of limiting metal ion provides strong evidence indicating that the B13 site of the tetramer species can bind Zn2+, Cd2+, or Ca2+ prior to hexamer formation and that such binding assists hexamer formation. Both the tetramer and the hexamer B13 sites were found to exhibit similar affinities for Zn2+ and Cd2+ (Kd congruent to 9 microM), whereas the tetramer B13 sites bind Ca2+ much more weakly (Kd congruent to 1 mM for tetramer vs 83 microM for hexamer). The second-order rate constants estimated for the association of Zn2+ and Cd2+ to the tetrameric site indicate that the loss of the first inner-sphere aqua ligand is the rate-limiting step for binding.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056521     DOI: 10.1021/bi00416a053

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

Review 1.  Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland.

Authors:  Shannon L Kelleher; Nicholas H McCormick; Vanessa Velasquez; Veronica Lopez
Journal:  Adv Nutr       Date:  2011-03-10       Impact factor: 8.701

2.  The aggregation behavior of zinc-free insulin studied by small-angle neutron scattering.

Authors:  J S Pedersen; S Hansen; R Bauer
Journal:  Eur Biophys J       Date:  1994       Impact factor: 1.733

3.  The lifetime of insulin hexamers.

Authors:  U Hassiepen; M Federwisch; T Mülders; A Wollmer
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

4.  Effects of insulin concentration and self-association on the partitioning of its A-21 cyclic anhydride intermediate to desamido insulin and covalent dimer.

Authors:  R T Darrington; B D Anderson
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

5.  Characterization of Zinc Influx Transporters (ZIPs) in Pancreatic β Cells: ROLES IN REGULATING CYTOSOLIC ZINC HOMEOSTASIS AND INSULIN SECRETION.

Authors:  Ying Liu; Battsetseg Batchuluun; Louisa Ho; Dan Zhu; Kacey J Prentice; Alpana Bhattacharjee; Ming Zhang; Farzaneh Pourasgari; Alexandre B Hardy; Kathryn M Taylor; Herbert Gaisano; Feihan F Dai; Michael B Wheeler
Journal:  J Biol Chem       Date:  2015-05-12       Impact factor: 5.157

6.  Zinc Intake and Status and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  José C Fernández-Cao; Marisol Warthon-Medina; Victoria H Moran; Victoria Arija; Carlos Doepking; Lluis Serra-Majem; Nicola M Lowe
Journal:  Nutrients       Date:  2019-05-08       Impact factor: 5.717

7.  The molecular basis of memory. Part 3: tagging with "emotive" neurotransmitters.

Authors:  Gerard Marx; Chaim Gilon
Journal:  Front Aging Neurosci       Date:  2014-04-07       Impact factor: 5.750

8.  Rapid-Acting and Human Insulins: Hexamer Dissociation Kinetics upon Dilution of the Pharmaceutical Formulation.

Authors:  Klaus Gast; Anja Schüler; Martin Wolff; Anja Thalhammer; Harald Berchtold; Norbert Nagel; Gudrun Lenherr; Gerrit Hauck; Robert Seckler
Journal:  Pharm Res       Date:  2017-07-31       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.